141 related articles for article (PubMed ID: 25811715)
1. Host APOBEC3G protein inhibits HCV replication through direct binding at NS3.
Zhu YP; Peng ZG; Wu ZY; Li JR; Huang MH; Si SY; Jiang JD
PLoS One; 2015; 10(3):e0121608. PubMed ID: 25811715
[TBL] [Abstract][Full Text] [Related]
2. Host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virus.
Peng ZG; Zhao ZY; Li YP; Wang YP; Hao LH; Fan B; Li YH; Wang YM; Shan YQ; Han YX; Zhu YP; Li JR; You XF; Li ZR; Jiang JD
Hepatology; 2011 Apr; 53(4):1080-9. PubMed ID: 21480314
[TBL] [Abstract][Full Text] [Related]
3. Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription.
Jin SY; Choi HY; Kim HS; Jung YT
Arch Virol; 2018 Jul; 163(7):1907-1914. PubMed ID: 29610985
[TBL] [Abstract][Full Text] [Related]
4. The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein.
Picard-Jean F; Bouchard S; Larivée G; Bisaillon M
Antiviral Res; 2014 Nov; 111():13-22. PubMed ID: 25193851
[TBL] [Abstract][Full Text] [Related]
5. Functional and Physical Interaction between the Arf Activator GBF1 and Hepatitis C Virus NS3 Protein.
Lebsir N; Goueslain L; Farhat R; Callens N; Dubuisson J; Jackson CL; Rouillé Y
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567983
[TBL] [Abstract][Full Text] [Related]
6. Intracytoplasmic stable expression of IgG1 antibody targeting NS3 helicase inhibits replication of highly efficient hepatitis C Virus 2a clone.
Chandra PK; Hazari S; Poat B; Gunduz F; Prabhu R; Liu G; Burioni R; Clementi M; Garry RF; Dash S
Virol J; 2010 Jun; 7():118. PubMed ID: 20529250
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the two cytidine deaminase domains in APOBEC3G.
Li X; Ma J; Zhang Q; Zhou J; Yin X; Zhai C; You X; Yu L; Guo F; Zhao L; Li Z; Zeng Y; Cen S
Virology; 2011 Jun; 414(2):130-6. PubMed ID: 21489586
[TBL] [Abstract][Full Text] [Related]
8. Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication.
Mukherjee S; Weiner WS; Schroeder CE; Simpson DS; Hanson AM; Sweeney NL; Marvin RK; Ndjomou J; Kolli R; Isailovic D; Schoenen FJ; Frick DN
ACS Chem Biol; 2014 Oct; 9(10):2393-403. PubMed ID: 25126694
[TBL] [Abstract][Full Text] [Related]
9. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
[TBL] [Abstract][Full Text] [Related]
10. APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription.
Li XY; Guo F; Zhang L; Kleiman L; Cen S
J Biol Chem; 2007 Nov; 282(44):32065-74. PubMed ID: 17855362
[TBL] [Abstract][Full Text] [Related]
11. Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid.
Derse D; Hill SA; Princler G; Lloyd P; Heidecker G
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2915-20. PubMed ID: 17299050
[TBL] [Abstract][Full Text] [Related]
12. Function analysis of sequences in human APOBEC3G involved in Vif-mediated degradation.
Zhang L; Saadatmand J; Li X; Guo F; Niu M; Jiang J; Kleiman L; Cen S
Virology; 2008 Jan; 370(1):113-21. PubMed ID: 17916373
[TBL] [Abstract][Full Text] [Related]
13. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase.
Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A
Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598
[TBL] [Abstract][Full Text] [Related]
14. The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA.
Guo F; Cen S; Niu M; Yang Y; Gorelick RJ; Kleiman L
J Virol; 2007 Oct; 81(20):11322-31. PubMed ID: 17670826
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HCV replication by oxysterol-binding protein-related protein 4 (ORP4) through interaction with HCV NS5B and alteration of lipid droplet formation.
Park IW; Ndjomou J; Wen Y; Liu Z; Ridgway ND; Kao CC; He JJ
PLoS One; 2013; 8(9):e75648. PubMed ID: 24069433
[TBL] [Abstract][Full Text] [Related]
16. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
[TBL] [Abstract][Full Text] [Related]
17. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.
Ulenga NK; Sarr AD; Hamel D; Sankale JL; Mboup S; Kanki PJ
AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1285-90. PubMed ID: 18851679
[TBL] [Abstract][Full Text] [Related]
18. Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity.
Phalaphol A; Thueng-In K; Thanongsaksrikul J; Poungpair O; Bangphoomi K; Sookrung N; Srimanote P; Chaicumpa W
J Virol Methods; 2013 Dec; 194(1-2):289-99. PubMed ID: 24036073
[TBL] [Abstract][Full Text] [Related]
19. Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33.
Wang S; Wu X; Pan T; Song W; Wang Y; Zhang F; Yuan Z
J Gen Virol; 2012 Jan; 93(Pt 1):83-92. PubMed ID: 21957124
[TBL] [Abstract][Full Text] [Related]
20. APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia.
Jin X; Brooks A; Chen H; Bennett R; Reichman R; Smith H
J Virol; 2005 Sep; 79(17):11513-6. PubMed ID: 16103203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
